Stocktoria

Vistagen Therapeutics, Inc. VTGN

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2010-10-18

Vistagen Therapeutics, Inc. insider transactions (Form 4)

InsiderRoleDateActionSharesPrice
Prince Joshua S.Chief Operating Officer2025-12-31Grant4,386$0.56

Source: SEC EDGAR filings · CIK 0001411685 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.